Margo B. Minissian, PhD, ACNP is a research scientist, clinical lipid specialist, and cardiology nurse practitioner at the Barbra Streisand Women’s Heart Center at the Cedars-Sinai Heart Institute. She is a published, principal investigator and co-investigator at Cedars-Sinai with multiple peer-reviewed publications. Her primary research interests focus on cardiovascular prevention. Dr. Minissian is funded by the National Institutes of Health, National Heart, Lung, and Blood Institute, to complete heart health screenings in ethnic minority women. She has partnered with local nursing organizations to complete this study, which takes place in minority communities in Los Angeles. Dr. Minissian has spoken at many professional organizations nationwide discussing the epidemic of women and heart disease, adverse pregnancy outcomes, and dyslipidemia complicated by statin myalgias. Dr. Minissian co-authored the ACC/AHA Secondary Prevention Guidelines, in which she chaired the smoking cessation section. In addition, she co-authored the 2016 and 2017 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Dr. Minissian received her master's in nursing from UCLA and completed her PhD in biological research at the UCLA School of Nursing.